KWKevin B. Wood

Kevin B. Wood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin B. Wood has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cooperative antibiotic response in coupled biofilm and planktonic E. faecalis communities

    by Gabriela Fernandes Martins, Keanu Alexander Guardiola-Flores, Luis Zaman, Jordan M Horowitz, Kelsey M Hallinen, Kevin Wood

    Bacterial communities grow as dynamic populations that respond to their environments. A clinically relevant example is the inactivation of beta-lactam antibiotics by intracellular beta-lactamase in E. faecalis resistant strains. In these populations, resistant bacteria act as antibiotic sinks, detoxifying the environment and allowing sensitive bacteria to survive treatment through a cooperative interaction. In this work, we study strongly coupled planktonic and biofilm populations of mixed sensitive-resistant E. faecalis bacteria under antibiotic stress using fluorescent microscopy. The presence of resistant bacteria in the system benefits both resistant and sensitive cells, leading to mixed planktonic and biofilm populations at super-inhibitory drug concentrations. We show that a beta-lactam antibiotic with or without the addition of a beta-lactam inhibitor can lead to a population inversion effect, characterized by a non-monotonic relation between initial and final fractions of resistant bacteria. The effect is observed in both the planktonic and biofilm populations and is modulated by the total initial cell density. A well-mixed model with competition mediated by resource sharing and cooperation from global degradation of toxins predicts the experimentally observed behavior. These observations suggest underlying population-level mechanisms that are largely independent of biofilm spatial structure.

  • Open Access

    Cooperative antibiotic response in coupled biofilm and planktonic E. faecalis communities

    by Gabriela Fernandes Martins, Keanu Alexander Guardiola-Flores, Luis Zaman, Jordan M. Horowitz, Kelsey M. Hallinen, Kevin Wood

    Bacterial communities grow as dynamic populations that respond to their environments. A clinically relevant example is the inactivation of beta-lactam antibiotics by intracellular beta-lactamase in E. faecalis resistant strains. In these populations, resistant bacteria act as antibiotic sinks, detoxifying the environment and allowing sensitive bacteria to survive treatment through a cooperative interaction. In this work, we study strongly coupled planktonic and biofilm populations of mixed sensitive-resistant E. faecalis bacteria under antibiotic stress using fluorescent microscopy. The presence of resistant bacteria in the system benefits both resistant and sensitive cells, leading to mixed planktonic and biofilm populations at super-inhibitory drug concentrations. We show that a beta-lactam antibiotic with or without the addition of a beta-lactam inhibitor can lead to a population inversion effect, characterized by a non-monotonic relation between initial and final fractions of resistant bacteria. The effect is observed in both the planktonic and biofilm populations and is modulated by the total initial cell density. A well-mixed model with competition mediated by resource sharing and cooperation from global degradation of toxins predicts the experimentally observed behavior. These observations suggest underlying population-level mechanisms that are largely independent of biofilm spatial structure.

  • Open Access

    Minding the gap: collective determinants of multiscale structure across interacting bacterial colonies

    by Jacob Moran, Michael Hinczewski, Suraj Shankar, Kevin B. Wood, Robert J. Woods, Luis Zaman

    A bacterial colony rarely exists in isolation – in natural habitats, colonies interact to form spatially structured communities across length and time scales. Eco-evolutionary feedbacks link these scales, such that structure at one level can influence another, yet the interplay between single- and multi-colony organization remains poorly understood. As a step toward addressing this, we develop a high-throughput platform to track population dynamics across spatially extended networks of colonies. A common structural feature observed at the multi-colony scale is the formation of a stable gap region between colonies, even when they are isogenic. Numerous studies observe similar patterns of behavior across species, with few resolving the underlying mechanism. Here, we ask: what are the minimal ingredients shaping this multi-colony structure? We focus on colonies of the opportunistic pathogen Enterococcus faecalis , a model organism for which this behavior has yet to be reported. By combining modeling and experiments, we show that both nutrient competition and direct growth inhibition control colony morphology and expansion of interacting colonies. We identify distinct regimes of gap formation, relating intra- and inter-colony spatial patterns to ecological interactions mediated at the cellular scale. Together, our results suggest that antagonism, even between isogenic populations through self-inhibition, is likely a common behavior of bacterial species in general.

  • Open Access

    Linking spatial drug heterogeneity to microbial growth dynamics in theory and experiment

    by Zhijian Hu, Yuzhen Wu, Tomas Freire, Erida Gjini, Kevin Wood

    Drugs play a central role in limiting bacterial population spread, yet laboratory studies typically assume well-mixed environments when assessing microbial drug responses. In contrast, bacteria in the human body often occupy spatially structured habitats where drug concentrations vary. Understanding how this heterogeneity shapes growth and decline is therefore essential for controlling infections and mitigating resistance evolution. Here, we developed a minimal robot-automated system to study how spatial drug heterogeneity affects short-term population dynamics in E. faecalis , a Gram-positive opportunistic pathogen. This system was combined with a theoretical framework to interpret and explain the observed outcomes. We first recapitulated the classic critical-patch-size model result: in a spatially homogeneous environment, a population persists in a finite domain only when growth outpaces diffusive losses at the boundaries. In heterogeneous environments, we found certain conditions that population persistence can depend critically on the spatial arrangement of the drug, even when its total amount is fixed. Using theoretical and experimental approaches, we identified the arrangements that produce the strongest growth and the fastest decline, revealing the range of possible outcomes under drug heterogeneity. We further tested this framework in more complex environments, including ring-shaped communities, and observed consistent arrangement-dependent behavior. Overall, our results extend the classical growth-condition framework to general heterogeneous environments and demonstrate that spatial drug arrangement - not only total dose - can strongly influence bacterial population dynamics. These findings highlight the importance of spatially structured dosing strategies and motivate further theoretical and experimental investigation.


  • Open Access

    Linezolid and levofloxacin: an uncommon pairing that suppresses evolution of resistance in E. faecalis

    by Noah M Schlachter, Keanu Guardiola Flores, Kevin B Wood, Jeff Maltas

    Drug combinations offer one potential strategy for slowing the evolution of antibiotic resistance. In this work, we investigate the evolution of drug resistance (strictly, the decrease in susceptibility) in populations of Enterococcus faecalis, an opportunistic human pathogen, exposed to different concentrations of the rarely used combination of linezolid (LZD) and levofloxacin (LEV). Using continuous culture bioreactors, we measured the two-dimensional dose–response surface of ancestral populations of E. faecalis, revealing that the LZD–LEV combination is strongly antagonistic, resulting in increased growth as LZD concentration is increased at a (sufficiently high) fixed concentration of LEV. Next, we performed multiday (50+ hour) evolution experiments by continually exposing populations to four different fixed-concentration combinations and then characterized isolates from adapted populations using whole genome sequencing and phenotypic dose–response curves. To control for differences in inhibition levels for different concentration combinations, we chose LZD–LEV combinations that fall along a single contour of constant growth in the two-drug space of LZD–LEV concentrations. Despite similar levels of initial inhibition across the four concentration combinations, we found that adaption is markedly different, with the most rapid adaptation and highest levels of evolved resistance occurring at combinations that include a high concentration of one drug and low concentration of the other. By contrast, we found almost no adaptation when both drugs were used at high concentrations, an initially surprising result that can be explained by simple drug-rescaling arguments applied to the antagonistic dose–response surface. Our results underscore the potential utility of a nonstandard (and strongly antagonistic) drug combination in suppressing resistance.

  • Open Access

    Deciphering and steering population-level response under spatial drug heterogeneity on microhabitat structures

    by Zhijian Hu, Kevin B Wood

    Bacteria and cancer cells inhabit spatially heterogeneous environments, where migration shapes microhabitat structures critical for colonization and metastasis. The interplay between growth, migration, and spatial structure complicates the prediction of population responses to drug treatment—such as clearance or persistence—even under the same spatially averaged growth rate. Accurately predicting these responses is essential for designing effective treatment strategies. Here, we propose a minimal growth-migration model to study population dynamics on discrete microhabitat structures under spatial drug heterogeneity. By applying a kernel transformation, we map the original structure to an effective fully connected graph and derive a new exact criterion for population response based on a regularized Laplacian kernel reweighted by local growth rates. This criterion connects to forest closeness centrality and yields analytical bounds and sufficient conditions for population growth or decline. We find that higher structural connectivity—like increased migration—generally promotes decline. Our framework also informs optimal spatial drug assignments, which reduce to selecting interconnected subcores in the effective complete graph. For partially controllable microhabitats or unknown drug distributions, we identify strategies that ensure population decline. Overall, our results offer a new theoretical perspective on drug response in spatially structured populations and provide practical guidance for optimizing spatially explicit dosing strategies in heterogeneous environments.

  • Top Cited Papers
    Open Access

    Spatial population dynamics of bacterial colonies with social antibiotic resistance

    by Marlis K. Denk-Lobnig, Kevin B. Wood

    Bacteria frequently inhabit surface-attached communities where rich “social” interactions can significantly alter their population-level behavior, including their response to antibiotics. Understanding these collective effects in spatially heterogeneous communities is an ongoing challenge. Here, we investigated the spatial organization that emerges from antibiotic exposure in initially randomly distributed communities containing antibiotic-resistant and -sensitive strains of Enterococcus faecalis , an opportunistic pathogen. We identified that a range of complex spatial structures emerged in the population homeland—the inoculated region that microbes inhabit prior to range expansion—which depended on initial colony composition and antibiotic concentration. We found that these arrangements were explained by cooperative interactions between resistant and sensitive subpopulations with a variable spatial scale, the result of dynamic zones of protection afforded to sensitive cells by growing populations of enzyme-producing resistant neighbors. Using a combination of experiments and mathematical models, we explored the complex spatiotemporal interaction dynamics that create these patterns, and predicted spatial arrangements of sensitive and resistant subpopulations under new conditions. We illustrated how spatial population dynamics in the homeland affect subsequent range expansion, both because they modulate the composition of the initial expanding front, and through long-range cooperation between the homeland and the expanding region. Finally, we showed that these spatial constraints resulted in populations whose size and composition differed markedly from matched populations in well-stirred (planktonic) cultures. These findings underscore the importance of spatial structure and cooperation, long-studied features in theoretical ecology, for determining the fate of bacterial communities under antibiotic exposure.


  • Open Access

    Dynamic collateral sensitivity profiles highlight opportunities and challenges for optimizing antibiotic treatments

    by Jeff Maltas, Anh Huynh, Kevin B Wood

    As failure rates for traditional antimicrobial therapies escalate, recent focus has shifted to evolution-based therapies to slow resistance. Collateral sensitivity—the increased susceptibility to one drug associated with evolved resistance to a different drug—offers a potentially exploitable evolutionary constraint, but the manner in which collateral effects emerge over time is not well understood. Here, we use laboratory evolution in the opportunistic pathogen Enterococcus faecalis to phenotypically characterize collateral profiles through evolutionary time. Specifically, we measure collateral profiles for 400 strain-antibiotic combinations over the course of 4 evolutionary time points as strains are selected in increasing concentrations of antibiotic. We find that at a global level—when results from all drugs are combined—collateral resistance dominates during early phases of adaptation, when resistance to the selecting drug is lower, while collateral sensitivity becomes increasingly likely with further selection. At the level of individual populations; however, the trends are idiosyncratic; for example, the frequency of collateral sensitivity to ceftriaxone increases over time in isolates selected by linezolid but decreases in isolates selected by ciprofloxacin. We then show experimentally how dynamic collateral sensitivity relationships can lead to time-dependent dosing windows that depend on finely timed switching between drugs. Finally, we develop a stochastic mathematical model based on a Markov decision process consistent with observed dynamic collateral profiles to show measurements across time are required to optimally constrain antibiotic resistance.


  • Open Access

    Spatial drug asymmetry modulates phenotypic diversity-migration relationships under resistance evolution

    by Zhijian Hu, Yuzhen Wu, Kevin Wood

    At long timescales, resistant phenotypes will emerge and be selected within the bacterial population as an evolutionary response to drug exposure. This phenomenon reduces the efficacy of drug therapies and thus compromises patient health. In spatially heterogeneous drug environments, recent evidence shows that migration can either promote or decelerate the evolution of antibiotic resistance, thereby affecting the rate of resistant phenotype emergence. However, another important quantitative aspect of resistance evolution—bacterial phenotypic diversity—has often been overlooked and remains challenging to investigate in spatially extended systems, both experimentally and clinically. In order to study how diversity is reshaped by migration across space, here we designed a minimal 2-well experimental system with spatial drug asymmetry. One well contained a bacteriostatic drug (Linezolid) at the minimum inhibitory concentration, while the other well served as a sanctuary with just media. We found that the relationship between diversity and migration follows the “Intermediate Disturbance Hypothesis” (IDH), with migration as the disturbance to each well. By varying the selective drug concentrations, we observed that the diversity-migration relationship changes, and IDH can disappear. This behavior was explained by an asymmetry parameter derived from a two-phenotype growth-migration dynamic model. To further validate how different spatial drug asymmetries modulate the diversity-migration relationship through this asymmetry parameter, we applied another bactericidal drug, Ampicillin, and observed similar results. In a more complex scenario involving both Linezolid and Ampicillin, four distinct phenotypes, including cross-resistant variants, emerged. Our asymmetry parameter successfully explained the diversity-migration relationship, with unique diversity dynamics such as multiple peaks appearing from the model. The minimal generalist-specialist framework predicted these unique behaviors through global fitness advantages. Our findings provide experimental support and theoretical explanations for the emergence of phenotypic diversity in clinical settings, such as gut-lung translocation. These insights may pave the way for improved clinical strategies to manage antibiotic resistance evolution.

  • Open Access

    Linking spatial drug heterogeneity to microbial growth dynamics in theory and experiment

    by Zhijian Hu, Yuzhen Wu, Tomas Freire, Erida Gjini, Kevin Wood

    Diffusion and migration play pivotal roles in microbial communities - shaping, for example, colonization in new environments and the maintenance of spatial structures of biodiversity. While previous research has extensively studied free diffusion, such as range expansion, there remains a gap in understanding the effects of biologically or physically deleterious confined environments. In this study, we examine the interplay between migration and spatial drug heterogeneity within an experimental meta-community of E. faecalis , a Gram-positive opportunistic pathogen. When the community is confined to spatially-extended habitats (‘islands’) bordered by deleterious conditions, we find that the population level response depends on the trade-off between the growth rate within the island and the rate of transfer into regions with harsher conditions, a phenomenon we explore by modulating antibiotic concentration within the island. In heterogeneous islands, composed of spatially patterned patches that support varying levels of growth, the population’s fate depends critically on the specific spatial arrangement of these patches - the same spatially averaged growth rate leads to diverging responses. These results are qualitatively captured by simple simulations, and analytical expressions which we derive using first-order perturbation approximations to reaction-diffusion models with explicit spatial dependence. Among all possible spatial arrangements, our theoretical and experimental findings reveal that the arrangement with the highest growth rates at the center most effectively mitigates population decline, while the arrangement with the lowest growth rates at the center is the least effective. Extending this approach to more complex experimental communities with varied spatial structures, such as a ring-structured community, further validates the impact of spatial drug arrangement. Our findings suggest new approaches to interpreting diverging clinical outcomes when applying identical drug doses and inform the possible optimization of spatially-explicit dosing strategies. Author summary: In this study, we develop an automated platform to experimentally investigate short-term population growth and migration dynamics under spatial drug heterogeneity. Our findings reveal that the collective spatial response of the population can vary significantly, even with the same migration rate and averaged drug dose, due to different spatial drug arrangements. By constructing a simple reaction-diffusion model, we observed that simulated short-term spatial growth rate closely matches the experimental data. Furthermore, this short-term spatial growth rate aligns well with the long-term spatial growth rate, defined by the largest eigenvalue, as the spatial system quickly enters the equilibrium growth state. Using concepts from perturbation theory, we derived an analytical relationship between the boundary diffusion effect, homogeneous growth effect, and heterogeneous effect. Our results highlight that in spatially-extended habitats, the spatial growth response is an emergent property. The bacterial population quickly enters equilibrium growth, suggesting that the spatial growth rate measured at an ecological scale may be used to predict resistance evolutionary behavior.